CHE 📈 Chemed - Overview
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US16359R1032
CHE: Hospice, Palliative, Care, Plumbing, Drain, Cleaning
Chemed Corporation is a diversified healthcare and plumbing services company, providing a range of essential services to patients and customers across the United States. Through its VITAS segment, the company delivers hospice and palliative care services to patients, leveraging a network of skilled physicians, registered nurses, home health aides, social workers, clergy, and volunteers. This comprehensive approach enables Chemed to provide high-quality, patient-centered care, addressing the complex needs of individuals with life-limiting illnesses. By operating a large network of caregivers, the company is able to offer personalized support and services to patients and their families, helping to improve the quality of life and reduce the burden of care.
In addition to its healthcare services, Chemed Corporation also operates a significant plumbing and drainage business through its Roto-Rooter segment. This division provides a broad range of services, including plumbing, drain cleaning, excavation, water restoration, and other related solutions to residential and commercial customers. The company's plumbing services are delivered through a combination of company-owned branches, independent contractors, and franchisees, allowing it to maintain a strong presence in the market and respond quickly to customer needs. By offering a reliable and efficient service, Chemed is able to help customers address plumbing and drainage issues, reducing the risk of property damage and minimizing disruption to their daily lives.
With a history dating back to 1970, Chemed Corporation has established itself as a stable and reputable player in the healthcare and plumbing services industries. Headquartered in Cincinnati, Ohio, the company is well-positioned to continue delivering high-quality services to its customers, while also driving growth and expansion through strategic investments and initiatives. As a publicly traded company, Chemed is committed to creating value for its shareholders, while also making a positive impact on the communities it serves. With its strong track record and diversified business model, the company is well-placed to navigate the evolving healthcare and plumbing services landscapes, and to capitalize on emerging opportunities for growth and development.
Additional Sources for CHE Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
CHE Stock Overview
Market Cap in USD | 8,207m |
Sector | Healthcare |
Industry | Medical Care Facilities |
GiC Sub-Industry | Health Care Services |
IPO / Inception | 1973-05-03 |
CHE Stock Ratings
Growth 5y | 27.6% |
Fundamental | 75.7% |
Dividend | 52.6% |
Rel. Strength Industry | -291 |
Analysts | 4.67/5 |
Fair Price Momentum | 454.45 USD |
Fair Price DCF | 539.79 USD |
CHE Dividends
Dividend Yield 12m | 0.34% |
Yield on Cost 5y | 0.42% |
Annual Growth 5y | 4.70% |
Payout Consistency | 96.8% |
CHE Growth Ratios
Growth Correlation 3m | -72% |
Growth Correlation 12m | -41.3% |
Growth Correlation 5y | 78.9% |
CAGR 5y | 4.01% |
CAGR/Mean DD 5y | 0.41 |
Sharpe Ratio 12m | -0.63 |
Alpha | -29.85 |
Beta | 0.64 |
Volatility | 22.59% |
Current Volume | 241.9k |
Average Volume 20d | 103.5k |
As of December 22, 2024, the stock is trading at USD 523.16 with a total of 241,923 shares traded.
Over the past week, the price has changed by -4.36%, over one month by -5.37%, over three months by -10.04% and over the past year by -9.81%.
Yes, based on ValueRay Fundamental Analyses, Chemed (NYSE:CHE) is currently (December 2024) a good stock to buy. It has a ValueRay Fundamental Rating of 75.68 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CHE as of December 2024 is 454.45. This means that CHE is currently overvalued and has a potential downside of -13.13%.
Chemed has received a consensus analysts rating of 4.67. Therefor, it is recommend to buy CHE.
- Strong Buy: 2
- Buy: 1
- Hold: 0
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, CHE Chemed will be worth about 499.1 in December 2025. The stock is currently trading at 523.16. This means that the stock has a potential downside of -4.6%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 663.7 | 26.9% |
Analysts Target Price | 592 | 13.2% |
ValueRay Target Price | 499.1 | -4.6% |